L
Lushi Tan
Researcher at Merck & Co.
Publications - 84
Citations - 1645
Lushi Tan is an academic researcher from Merck & Co.. The author has contributed to research in topics: Enantioselective synthesis & Ketone. The author has an hindex of 20, co-authored 80 publications receiving 1412 citations.
Papers
More filters
Journal ArticleDOI
Practical asymmetric synthesis of Efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor
Michael E. Pierce,Rodney L. Parsons,Lilian A. Radesca,Young S. Lo,Stuart Silverman,James R. Moore,Q. Islam,Anusuya Choudhury,Joseph M. Fortunak,Dieu Nguyen,Chi Luo,Susan J. Morgan,Wayne P. Davis,Pat N. Confalone,Cheng-yi Chen,Richard D. Tillyer,Lisa F. Frey,Lushi Tan,Feng Xu,Dalian Zhao,Andrew S. Thompson,Edward G. Corley,Edward J. J. Grabowski,Robert A. Reamer,Paul J. Reider +24 more
TL;DR: In this article, a highly enantioselective and practical synthesis of the HIV-1 reverse transcriptase inhibitor efavirenz (1) is described, which proceeds in 62% overall yield in seven steps from 4-chloroaniline (6) in excellent chemical and optical purity.
Journal ArticleDOI
A Novel, Highly Enantioselective Ketone Alkynylation Reaction Mediated by Chiral Zinc Aminoalkoxides
TL;DR: Kilogram-scale synthesis of the HIV reverse transcriptase inhibitor efavirenz was achieved by means of a highly enantioselective alkynylation of prochiral ketones 1 with alkynyllithium or alkynymagnesium reagents in the presence of chiral zinc aminoalkoxides as mediators.
Journal ArticleDOI
Rhodium‐Catalyzed Regioselective C7‐Functionalization of N‐Pivaloylindoles
TL;DR: An efficient rhodium-catalyzed method for direct C-H functionalization at the C7 position of a wide range of indoles has been developed, with good to excellent yields of alkenylation products.
Journal ArticleDOI
Dynamic kinetic resolution: asymmetric transfer hydrogenation of alpha-alkyl-substituted beta-ketoamides.
TL;DR: Dynamic kinetic resolution (deracemization) of various alpha-alkyl-substituted beta-ketoamides 1 via asymmetric transfer hydrogenation proceeded efficiently to give the corresponding syn-beta-hydroxy amides 3 in high diastereo- and enantioselectivities.
Journal ArticleDOI
An Efficient Synthesis of an αvβ3 Antagonist
Nobuyoshi Yasuda,Yi Hsiao,Mark S. Jensen,Nelo R. Rivera,Chunhua Yang,Kenneth M. Wells,James Yau,Michael Palucki,Lushi Tan,Peter G. Dormer,Ralph P. Volante,David L. Hughes,Paul J. Reider +12 more
TL;DR: A practical preparation of an alpha(v)beta(3) antagonist is reported, which consists of three key components, a tetrahydronaphthyridine moiety, a beta-alanine moieties, and a central imidazolidone moiety.